Alzheimer Disease Clinical Trials in Los Angeles, California

5 studies are recruiting for alzheimer disease in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

   The goal of this clinical trial is to learn if using large-coil (or "deep") repetitive transcranial magnetic stimulation (rTMS) targeting the precuneus and surrounding areas is feasible, tolerable, and potentially efficacious for memory in Alzheimer's Disease. Previous work studying rTMS in Alzheim…

   Stage

   Phase 1

   Ages

   55 to 100

   Site

   UCLA TMS Clinical and Research Service, Los Angeles, California

   Run by

   University of California, Los Angeles

   See if you can join NCT06597942 on ClinicalTrials.gov

2. A Study of LY3439539 in Participants With Alzheimer's Disease

   The purpose of this study is to see how LY3439539 affects certain proteins found in the spinal fluid of participants with Alzheimer's disease. Participation in the study will last approximately 9 months with visits about once a month.

   Stage

   Phase 1

   Ages

   50 to 85

   Site

   Inglewood Clinical, Los Angeles, California

   Locations

   11 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07598370 on ClinicalTrials.gov

3. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

   The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.

   Stage

   Phase 3

   Ages

   55 to 90

   Site

   USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles, California

   Locations

   293 in total

   Run by

   Karuna Therapeutics, Inc., a Bristol Myers Squibb company

   See if you can join NCT06585787 on ClinicalTrials.gov

4. [18F]PI-2620 Phase 3 Histopathological Study

   This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with [18F]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after de…

   Stage

   Phase 3

   Ages

   50 and older

   Site

   UC Los Angeles, Los Angeles, California

   Locations

   25 in total

   Run by

   Lantheus Biosciences Ltd.

   See if you can join NCT05641688 on ClinicalTrials.gov

5. Cardiac-Control Affecting Learning Through Mindfulness (CALM)

   Some types of meditation lead heart rate to become more steady as breathing quiets whereas others lead to large heart rate swings up and down (oscillations) as breathing becomes deeper and slower. The current study is designed to investigate how daily mindfulness practice with heart rate biofeedbac…

   Stage

   Not phased

   Ages

   50 to 70

   Site

   University of Southern California, Los Angeles, California

   Run by

   University of Southern California

   See if you can join NCT06410157 on ClinicalTrials.gov